IFNA2 抗体
(Interferon, alpha 2 (IFNA2))
This gene is a member of the alpha interferon gene cluster on chromosome 9. The encoded protein is a cytokine produced in response to viral infection. Use of the recombinant form of this protein has been shown to be effective in reducing the symptoms and duration of the common cold. [provided by RefSeq, Jun 2011].
recommended
recommended
recommended
IFNA2 抗体 by 适用
Find IFNA2 抗体 for a variety of species such as anti-Human IFNA2, anti-Monkey IFNA2, anti-Mouse IFNA2. The species listed below are among those available. Click on a link to go to the corresponding products.
IFNA2 抗体 by 抗体来源
Find IFNA2 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
IFNA2 抗体 by 抗原表位
Find IFNA2 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.
IFNA2 抗体 by 克隆形成能力
Find available monoclonal or polyclonal IFNA2 抗体. Click on a link to go to the corresponding products.
IFNA2 抗体 by 克隆
Find IFNA2 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
Popular IFNA2 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
ELISA, WB, IHC, IF
Validations
- (6)
Cat. No.
ABIN7156561
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (4)
Cat. No.
ABIN7431266
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IF, ICC, IHC (p)
Validations
- (3)
Cat. No.
ABIN2856588
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (2)
Cat. No.
ABIN516844
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, WB
Validations
- (2)
Cat. No.
ABIN516845
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, WB
Validations
- (2)
Cat. No.
ABIN516864
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, WB, IHC
Validations
- (2)
Cat. No.
ABIN6257754
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Rat
Application
WB, IHC, ICC
Validations
- (3)
Cat. No.
ABIN5013763
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, WB
Validations
- (1)
Cat. No.
ABIN669801
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (1)
Cat. No.
ABIN7425755
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (1)
Cat. No.
ABIN516843
Quantity
50 μL
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, WB
Validations
- (1)
Cat. No.
ABIN516846
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, IF, FACS, Coat, BP, AcA
Validations
- (1)
Cat. No.
ABIN6939691
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, WB, IHC, IHC (p)
Validations
- (1)
Cat. No.
ABIN2450722
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human, Monkey
Application
WB, IHC, ICC, IHC (p)
Validations
- (1)
Cat. No.
ABIN1904484
Quantity
100 μL
Datasheet
Datasheet
Latest Publications for our IFNA2 抗体
: "Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice." in: Molecular cancer therapeutics, Vol. 18, Issue 9, pp. 1544-1554, (2020) (PubMed).: "Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer." in: Scientific reports, Vol. 8, Issue 1, pp. 12954, (2019) (PubMed).
: "Distribution of therapeutic proteins into thoracic lymph after intravenous administration is protein size-dependent and primarily occurs within the liver and mesentery." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 272, pp. 17-28, (2019) (PubMed).
: "Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Issue 3, pp. E478-E487, (2018) (PubMed).
: "An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration." in: Biomacromolecules, Vol. 18, Issue 9, pp. 2866-2875, (2018) (PubMed).
: "Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes." in: Nutrients, Vol. 9, Issue 9, (2018) (PubMed).
: "Human monocytes represent a competitive source of interferon-alpha in peripheral blood." in: Clinical immunology (Orlando, Fla.), Vol. 127, Issue 2, pp. 252-64, (2008) (PubMed).
: "Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2." in: Immunology letters, Vol. 35, Issue 3, pp. 281-4, (1993) (PubMed).
: "Mapping of two immunodominant structures on human interferon alpha 2c and their role in binding to cells." in: Molecular immunology, Vol. 28, Issue 11, pp. 1289-97, (1992) (PubMed).
: "Interferons and their actions." in: Annual review of biochemistry, Vol. 56, pp. 727-77, (1987) (PubMed).
Aliases for IFNA2 抗体
interferon alpha 2 (IFNA2) 抗体interferon alpha 2 (Ifna2) 抗体
interferon, alpha 2 (IFNA2) 抗体
interferon alpha 2 (ifna2) 抗体
interferon-alpha-2 (IFN-ALPHA2) 抗体
interferon alpha-2 (LOC102142148) 抗体
Ifa2 抗体
IFN-alphaA 抗体
IFNA 抗体
IFNA2 抗体
IFNA2B 抗体
INFA2 抗体
您还需要查找其他产品吗？
You are here:
